Bias in Treatment Assignment in Controlled Clinical Trials

Matthew W. Gillman, Desmond K. Runyan, Marvin Zelen, Kenneth H. Hupart, Mark Linzer, Lawrence I. Bonchek, Thomas C. Chalmers, Henry Sacks, Harry Smith

Research output: Contribution to journalLetterpeer-review

6 Scopus citations

Abstract

To the Editor: Like Chalmers et al., we believe in “the necessity for blinding the randomization process in a controlled trial” in order to minimize bias (Dec. 1 issue).* However, we found their paper to be an even more dramatic example of the insidiousness of this problem in the clinical literature than they might have intended. The authors themselves have fallen prey to the same shortcomings — namely, the use of maldislributed variables and historical controls — that they decry. One can see this by first examining their Table 2, in which some “types of treatments studied” are maldistributed: for.

Original languageEnglish (US)
Pages (from-to)1610-1612
Number of pages3
JournalNew England Journal of Medicine
Volume310
Issue number24
DOIs
StatePublished - Jun 14 1984

Fingerprint Dive into the research topics of 'Bias in Treatment Assignment in Controlled Clinical Trials'. Together they form a unique fingerprint.

Cite this